Santen Pharmaceutical (4536) Income Statement & Earnings

1761.0
+13.0+0.74%

20min DelayMarket Closed Jan 23 15:30 JST

567.52BMarket Cap16.98P/E (Static)

Santen Pharmaceutical (4536) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2025

(FY)Mar 31, 2025

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

Total revenue

-8.07%68.74B

-0.65%300B

3.29%74.77B

8.22%301.97B

-0.15%79.13B

8.69%77.03B

15.83%73.42B

10.46%72.39B

4.80%279.04B

12.48%79.25B

Cost of revenue

-1.21%31.62B

4.64%128.98B

6.60%32.01B

9.12%123.26B

15.11%31.66B

8.79%32.15B

7.04%29.43B

5.70%30.02B

2.99%112.95B

1.98%27.5B

Gross profit

-13.21%37.12B

-4.30%171.03B

0.95%42.77B

7.60%178.71B

-8.26%47.48B

8.61%44.88B

22.57%43.99B

14.11%42.37B

6.07%166.09B

19.00%51.75B

Operating expense

-0.22%29.55B

-11.43%124.15B

-0.02%29.61B

-17.15%140.17B

0.90%45.09B

4.23%33.82B

-49.97%31.64B

2.85%29.62B

40.16%169.18B

31.52%44.69B

Selling and administrative expenses

-0.82%21.2B

-3.89%87.97B

1.49%21.38B

-4.91%91.53B

-12.92%26.78B

-7.03%21.58B

-3.32%22.11B

8.44%21.07B

13.91%96.26B

27.21%30.76B

-General and administrative expense

-0.82%21.2B

-3.89%87.97B

1.49%21.38B

-4.91%91.53B

-12.92%26.78B

-7.03%21.58B

-3.32%22.11B

8.44%21.07B

13.91%96.26B

27.21%30.76B

Research and development costs

12.77%6.21B

-5.17%24.1B

-12.65%5.5B

-10.18%25.42B

8.96%7.21B

-22.49%5.75B

-14.08%6.16B

-11.24%6.3B

7.28%28.3B

-12.66%6.62B

Depreciation and amortization

-10.56%2.18B

-6.96%8.81B

4.47%2.43B

-0.49%9.47B

4.14%2.39B

15.74%2.38B

-9.23%2.37B

-8.81%2.33B

-2.22%9.52B

-7.50%2.29B

-Depreciation

--0

-Amortization

-10.56%2.18B

-6.96%8.81B

4.47%2.43B

-0.49%9.47B

4.14%2.39B

15.74%2.38B

-9.23%2.37B

-8.81%2.33B

-2.22%9.52B

-7.50%2.29B

Other operating expenses

-62.46%134M

-74.81%3.85B

60.81%357M

-60.39%15.3B

10.82%8.9B

13,253.13%4.27B

-93.77%1.91B

393.33%222M

3,309.44%38.63B

1,580.13%8.03B

Total other operating income

179.37%176M

-61.95%589M

-79.21%63M

-56.07%1.55B

-93.94%182M

-40.84%155M

--908M

-8.73%303M

237.87%3.52B

313.93%3B

Operating profit

-42.44%7.57B

21.64%46.88B

3.18%13.16B

1,347.25%38.54B

-66.25%2.38B

24.63%11.06B

145.15%12.35B

52.99%12.75B

-108.61%-3.09B

-25.77%7.06B

Net non-operating interest income (expenses)

-141.36%-122M

217.77%1.29B

-66.55%295M

-215.61%-1.09B

-125.67%-1.42B

68.87%-217M

-19.29%-334M

-30.11%882M

-125.94%-346M

-173.71%-631M

Non-operating interest income

-10.68%627M

154.58%4B

-33.14%702M

36.34%1.57B

62.89%259M

13.55%486M

18.75%152M

-24.19%1.05B

-54.66%1.15B

-88.05%159M

Non-operating interest expense

84.03%749M

1.95%2.72B

142.26%407M

77.72%2.66B

113.04%1.68B

-37.51%703M

19.12%486M

36.59%168M

23.99%1.5B

66.32%790M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

90.96%-685M

-220.70%-7.58B

-636.13%-4.65B

-103.45%-1.36B

-48.99%-809M

-46.64%-764M

-47.26%-2.36B

-50.96%-631M

Special income (charges)

Other non-operating income (expenses)

Income before tax

-44.61%7.45B

58.94%47.48B

4.52%13.45B

615.16%29.87B

-163.60%-3.69B

26.30%9.48B

139.77%11.21B

41.81%12.87B

-116.28%-5.8B

-41.73%5.79B

Income tax

-44.18%1.59B

266.70%11.63B

15.76%2.84B

-65.47%3.17B

-181.21%-3.81B

38.09%2.18B

335.69%2.34B

3.24%2.46B

8.98%9.18B

128.73%4.69B

Net income

-44.73%5.86B

34.27%35.85B

1.87%10.61B

278.22%26.7B

-88.87%123M

23.17%7.31B

130.86%8.86B

55.52%10.41B

-155.11%-14.98B

-86.00%1.11B

Net income continuous operations

-44.73%5.86B

34.27%35.85B

1.87%10.61B

278.22%26.7B

-88.87%123M

23.17%7.31B

130.87%8.86B

55.52%10.41B

-155.11%-14.98B

-86.00%1.11B

Noncontrolling interests

42.31%-15M

-771.67%-403M

-1,200.00%-26M

271.43%60M

945.45%93M

41.30%-27M

60.00%-4M

-106.25%-2M

-20.69%-35M

-145.83%-11M

Net income attributable to the company

-44.72%5.88B

36.09%36.26B

2.10%10.63B

278.23%26.64B

-97.40%29M

22.67%7.33B

130.89%8.87B

56.30%10.41B

-154.92%-14.95B

-85.82%1.12B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-44.72%5.88B

36.09%36.26B

2.10%10.63B

278.23%26.64B

-97.40%29M

22.67%7.33B

130.89%8.87B

56.30%10.41B

-154.92%-14.95B

-85.82%1.12B

Gross dividend payment

Basic earnings per share

-41.47%17.32

43.24%103.98

5.94%29.59

288.06%72.59

-86.96%0.33

33.76%20.72

132.56%24.6

66.35%27.93

-156.71%-38.6

-87.14%2.53

Diluted earnings per share

-41.42%17.28

43.26%103.68

5.92%29.5

287.49%72.37

-87.35%0.32

33.64%20.66

132.45%24.52

66.07%27.85

-156.79%-38.6

-87.12%2.53

Dividend per share

9.09%36

3.13%33

6.25%17

0.00%16

0.00%32

0.00%16

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Jun 30, 2025	(FY)Mar 31, 2025	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023
Total revenue	-8.07%68.74B	-0.65%300B	3.29%74.77B	8.22%301.97B	-0.15%79.13B	8.69%77.03B	15.83%73.42B	10.46%72.39B	4.80%279.04B	12.48%79.25B
Cost of revenue	-1.21%31.62B	4.64%128.98B	6.60%32.01B	9.12%123.26B	15.11%31.66B	8.79%32.15B	7.04%29.43B	5.70%30.02B	2.99%112.95B	1.98%27.5B
Gross profit	-13.21%37.12B	-4.30%171.03B	0.95%42.77B	7.60%178.71B	-8.26%47.48B	8.61%44.88B	22.57%43.99B	14.11%42.37B	6.07%166.09B	19.00%51.75B
Operating expense	-0.22%29.55B	-11.43%124.15B	-0.02%29.61B	-17.15%140.17B	0.90%45.09B	4.23%33.82B	-49.97%31.64B	2.85%29.62B	40.16%169.18B	31.52%44.69B
Selling and administrative expenses	-0.82%21.2B	-3.89%87.97B	1.49%21.38B	-4.91%91.53B	-12.92%26.78B	-7.03%21.58B	-3.32%22.11B	8.44%21.07B	13.91%96.26B	27.21%30.76B
-General and administrative expense	-0.82%21.2B	-3.89%87.97B	1.49%21.38B	-4.91%91.53B	-12.92%26.78B	-7.03%21.58B	-3.32%22.11B	8.44%21.07B	13.91%96.26B	27.21%30.76B
Research and development costs	12.77%6.21B	-5.17%24.1B	-12.65%5.5B	-10.18%25.42B	8.96%7.21B	-22.49%5.75B	-14.08%6.16B	-11.24%6.3B	7.28%28.3B	-12.66%6.62B
Depreciation and amortization	-10.56%2.18B	-6.96%8.81B	4.47%2.43B	-0.49%9.47B	4.14%2.39B	15.74%2.38B	-9.23%2.37B	-8.81%2.33B	-2.22%9.52B	-7.50%2.29B
-Depreciation	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-Amortization	-10.56%2.18B	-6.96%8.81B	4.47%2.43B	-0.49%9.47B	4.14%2.39B	15.74%2.38B	-9.23%2.37B	-8.81%2.33B	-2.22%9.52B	-7.50%2.29B
Other operating expenses	-62.46%134M	-74.81%3.85B	60.81%357M	-60.39%15.3B	10.82%8.9B	13,253.13%4.27B	-93.77%1.91B	393.33%222M	3,309.44%38.63B	1,580.13%8.03B
Total other operating income	179.37%176M	-61.95%589M	-79.21%63M	-56.07%1.55B	-93.94%182M	-40.84%155M	--908M	-8.73%303M	237.87%3.52B	313.93%3B
Operating profit	-42.44%7.57B	21.64%46.88B	3.18%13.16B	1,347.25%38.54B	-66.25%2.38B	24.63%11.06B	145.15%12.35B	52.99%12.75B	-108.61%-3.09B	-25.77%7.06B
Net non-operating interest income (expenses)	-141.36%-122M	217.77%1.29B	-66.55%295M	-215.61%-1.09B	-125.67%-1.42B	68.87%-217M	-19.29%-334M	-30.11%882M	-125.94%-346M	-173.71%-631M
Non-operating interest income	-10.68%627M	154.58%4B	-33.14%702M	36.34%1.57B	62.89%259M	13.55%486M	18.75%152M	-24.19%1.05B	-54.66%1.15B	-88.05%159M
Non-operating interest expense	84.03%749M	1.95%2.72B	142.26%407M	77.72%2.66B	113.04%1.68B	-37.51%703M	19.12%486M	36.59%168M	23.99%1.5B	66.32%790M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests		90.96%-685M	0	-220.70%-7.58B	-636.13%-4.65B	-103.45%-1.36B	-48.99%-809M	-46.64%-764M	-47.26%-2.36B	-50.96%-631M
Special income (charges)
Other non-operating income (expenses)
Income before tax	-44.61%7.45B	58.94%47.48B	4.52%13.45B	615.16%29.87B	-163.60%-3.69B	26.30%9.48B	139.77%11.21B	41.81%12.87B	-116.28%-5.8B	-41.73%5.79B
Income tax	-44.18%1.59B	266.70%11.63B	15.76%2.84B	-65.47%3.17B	-181.21%-3.81B	38.09%2.18B	335.69%2.34B	3.24%2.46B	8.98%9.18B	128.73%4.69B
Net income	-44.73%5.86B	34.27%35.85B	1.87%10.61B	278.22%26.7B	-88.87%123M	23.17%7.31B	130.86%8.86B	55.52%10.41B	-155.11%-14.98B	-86.00%1.11B
Net income continuous operations	-44.73%5.86B	34.27%35.85B	1.87%10.61B	278.22%26.7B	-88.87%123M	23.17%7.31B	130.87%8.86B	55.52%10.41B	-155.11%-14.98B	-86.00%1.11B
Noncontrolling interests	42.31%-15M	-771.67%-403M	-1,200.00%-26M	271.43%60M	945.45%93M	41.30%-27M	60.00%-4M	-106.25%-2M	-20.69%-35M	-145.83%-11M
Net income attributable to the company	-44.72%5.88B	36.09%36.26B	2.10%10.63B	278.23%26.64B	-97.40%29M	22.67%7.33B	130.89%8.87B	56.30%10.41B	-154.92%-14.95B	-85.82%1.12B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-44.72%5.88B	36.09%36.26B	2.10%10.63B	278.23%26.64B	-97.40%29M	22.67%7.33B	130.89%8.87B	56.30%10.41B	-154.92%-14.95B	-85.82%1.12B
Gross dividend payment
Basic earnings per share	-41.47%17.32	43.24%103.98	5.94%29.59	288.06%72.59	-86.96%0.33	33.76%20.72	132.56%24.6	66.35%27.93	-156.71%-38.6	-87.14%2.53
Diluted earnings per share	-41.42%17.28	43.26%103.68	5.92%29.5	287.49%72.37	-87.35%0.32	33.64%20.66	132.45%24.52	66.07%27.85	-156.79%-38.6	-87.12%2.53
Dividend per share	0	9.09%36	0	3.13%33	6.25%17	0	0.00%16	0	0.00%32	0.00%16
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More

Futubull Options Sir

Jan 19 17:47

Options Weekly 0119 | Greenland tariff standoff, gold and silver surge again, shocking reversal in Fed chair nominee! Watch Intel, Netflix earnings reports

杨杨得億

Jan 20 13:42

The real danger in the 2026 market isn't black swan events, but rather the changes you've become accustomed to ignoring.